Education Sessions
Hot Topic – In Search of the GMPs (209)
| 29 October 08.15-11.15 | Track: Innovation |
ISPE CEUs: 0.4
(PDF Current as of 17 September 2008)
The FDA received numerous comments from industry regarding the proposed revisions to the GMPs. Due to the number and content of those comments, the Agency removed the proposed revisions from posting and went back to the drawing board in April, 2008. What has happened since then and what does this mean to the industry? This session will explore the current state of revision, review some of the comments and hear from industry and regulators on how the GMPs will be impacted by events and other initiatives shaping the global marketplace today.
Session Leader
- Paul D'Eramo, Executive Director, Johnson & Johnson, USA
Session Speaker
- Timothy Flanigan, , , USA